Mirum Pharmaceuticals Inc (MIRM) Company Profile & Statistics

Mirum Pharmaceuticals Inc
MIRM
(Nasdaq - US)
Closed
46.73
+1.58 (+3.50%)
in:usd•As of: Nov 27, 2024 15:59 UTC -5
Open
45.27
High
46.87
Low
44.75

About Mirum Pharmaceuticals Inc

CEO

Christopher Peetz

Headquarters

950 tower lane, suite 1050

foster city, ca 94404, united states

Auditor

Ernst & Young LLP

Employees

264

Share Holders

Website

www.mirumpharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's product candidate consists of maralixibat, an investigational oral drug in development for progressive familial intrahepatic cholestasis and Alagille syndrome. Mirum Pharmaceuticals Inc. is based in Foster City, United States.

Mirum Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	2.24B
Enterprise Value	2.33B
Enterprise Value/EBITDA (ttm)	-32.67
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	9.10
Price to Sales (ttm)	6.92
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	72.32%
Operating Margin (ttm)	-31.69%
Profit Margin (ttm)	-33.79%
Return on Equity (ttm)	-41.22%
Return on Invested Capital (ttm)	-18.33%
Return on Assets (ttm)	-14.81%

Income Statement

Revenue (ttm)	307.03M
Revenue Per Share (ttm)	6.40
Gross Profit (ttm)	223.14M
EBITDA (ttm)³	-71.26M
Net Income Avi to Common (ttm)	-99.81M
Diluted EPS (ttm)	-2.02

Share Statistics

Beta (5Y Monthly)	1.16
52-Week Change	45.58%
S&P500 52-Week Change	31.83%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	48.00M
Dividend Yield	0.00%
Float ⁴	37.03M
% Held by Insiders	22.87%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	284.44M
Total Cash Per Share (mrq)	5.93
Total Debt (mrq)	307.67M
Total Debt/Equity (mrq)	132.60%
Current Ratio (mrq)	3.34%
Quick Ratio (mrq)	3.15%
Book Value Per Share (mrq)	4.84

Cash Flow

Operating Cash Flow Per Share (ytd)	0.32
Free Cash Flow (ytd)	14.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Mirum Pharmaceuticals Inc

Trade With A Regulated Broker